Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1981 1
1983 1
1987 1
1988 2
1989 2
1992 1
1993 3
1994 1
1995 2
1998 2
1999 1
2000 1
2001 3
2002 1
2003 1
2004 3
2005 2
2006 5
2007 6
2008 4
2009 3
2010 3
2011 6
2012 5
2013 10
2014 12
2015 5
2016 5
2017 5
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 24855280

86 results
Results by year
Filters applied: . Clear all
Page 1
Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.
van den Brand JA, van Dijk PR, Hofstra JM, Wetzels JF. van den Brand JA, et al. Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1066-73. doi: 10.2215/CJN.08880813. Epub 2014 May 22. Clin J Am Soc Nephrol. 2014. PMID: 24855280 Free PMC article.
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF. Hofstra JM, et al. Nephrol Dial Transplant. 2010 Jan;25(1):129-36. doi: 10.1093/ndt/gfp390. Epub 2009 Aug 8. Nephrol Dial Transplant. 2010. PMID: 19666912 Clinical Trial.
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.
Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA. Hoxha E, et al. Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29. Clin J Am Soc Nephrol. 2014. PMID: 25267554 Free PMC article.
Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ, Wetzels JF. Branten AJ, et al. Clin Nephrol. 2001 Jul;56(1):1-9. Clin Nephrol. 2001. PMID: 11499653
Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.
Jorgenson MR, Descourouez JL, Singh T, Astor BC, Panzer SE. Jorgenson MR, et al. Pharmacotherapy. 2018 Jan;38(1):51-57. doi: 10.1002/phar.2059. Epub 2017 Dec 18. Pharmacotherapy. 2018. PMID: 29136299
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V. Jha V, et al. J Am Soc Nephrol. 2007 Jun;18(6):1899-904. doi: 10.1681/ASN.2007020166. Epub 2007 May 9. J Am Soc Nephrol. 2007. PMID: 17494881 Free article. Clinical Trial.
Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF. du Buf-Vereijken PW, et al. Nephrol Dial Transplant. 2004 Aug;19(8):2036-43. doi: 10.1093/ndt/gfh312. Epub 2004 Jun 8. Nephrol Dial Transplant. 2004. PMID: 15187191
Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy.
Khan S, Bolton WK. Khan S, et al. Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1001-4. doi: 10.2215/CJN.04130414. Epub 2014 May 22. Clin J Am Soc Nephrol. 2014. PMID: 24855281 Free PMC article. No abstract available.
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF 3rd, Niles JL. Cortazar FB, et al. BMC Nephrol. 2017 Feb 1;18(1):44. doi: 10.1186/s12882-017-0459-z. BMC Nephrol. 2017. PMID: 28143416 Free PMC article.
Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
Hofstra JM, Wetzels JF. Hofstra JM, et al. Nephrol Dial Transplant. 2008 Nov;23(11):3534-8. doi: 10.1093/ndt/gfn350. Epub 2008 Jun 17. Nephrol Dial Transplant. 2008. PMID: 18559961
86 results
Jump to page